You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IOV-2001

Showing 1 - 25 of 436
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • IOV-2001
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 31, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Healthy Trial (SHR-2001, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 4, 2023

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)

Not yet recruiting
  • Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
  • NTLA-2001
  • Placebo
  • (no location specified)
Nov 8, 2023

Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ISB 2001
  • Benowa, Queensland, Australia
    Pindara Private Hospital
May 18, 2023

Narcolepsy Type 1, Narcolepsy Type 2 Trial (TAK-861)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy Type 2
  • (no location specified)
Mar 31, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Not yet recruiting
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Jan 24, 2023

    Intensive Lifestyle Intervention on Employment, Earnings, and

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • Intensive lifestyle intervention (ILI)
    • Diabetes support and education (DSE)
    • (no location specified)
    Sep 29, 2022

    Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)

    Active, not recruiting
    • Severe Hypertriglyceridemia
    • Beverly Hills, California
    • +72 more
    Nov 29, 2022

    Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

    Enrolling by invitation
    • Tuberous Sclerosis Complex
    • Phoenix, Arizona
    • +13 more
    Jan 24, 2023

    Regorafenib in Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

    Recruiting
    • Glioblastoma Multiforme
    • Regorafenib 40 MG Oral Tablet [STIVARGA]
    • Acquaviva Delle Fonti, BA, Italy
    • +28 more
    Mar 31, 2022

    Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,

    Recruiting
    • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
    • +2 more
    • NTLA-2001
    • Paris, France
    • +3 more
    Nov 29, 2022

    Digestive and Social Functions of SPN

    Recruiting
    • Solid Pseudopapillary Tumor of the Pancreas
    • Pancreas Cancer
    • observational study
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 1, 2022

    Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

    Recruiting
    • Human Immunodeficiency Virus
    • +2 more
    • Seattle, Washington
      UW Positve Research, Harborview Medical Center
    May 8, 2023

    Botulinum Toxin for Chronic Neuropathic Pain

    Recruiting
    • Neuralgia
    • Chronic Pain
    • Botulinum toxin type A
    • Køge, Denmark
      University Hospital of regions Zealand
    Sep 11, 2023

    Subjects Displaying Facial Ageing Trial in Manhattan Beach, San Diego (Skinstylus microneedling device)

    Recruiting
    • Subjects Displaying Facial Ageing
    • Skinstylus microneedling device
    • Manhattan Beach, California
    • +1 more
    Sep 12, 2023

    Dyslipidemias Trial in Australia, New Zealand (ARO-APOC3)

    Enrolling by invitation
    • Dyslipidemias
    • Beverly Hills, California
    • +36 more
    Jan 13, 2023

    Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

    Recruiting
    • Leukemia, Myeloid, Acute
    • +2 more
    • H3B-8800 (RVT-2001)
    • Stanford, California
    • +26 more
    Mar 23, 2022

    Mixed Dyslipidemia Trial in Worldwide (ARO-ANG3, Placebo)

    Active, not recruiting
    • Mixed Dyslipidemia
    • Huntington Park, California
    • +23 more
    Jun 27, 2022

    Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

    Active, not recruiting
    • Squamous Non-small Cell Lung Cancer
    • Nivolumab 10 MG/ML Intravenous Solution
    • Best Supportive Care
    • Imola, Bologna, Italy
    • +30 more
    Sep 30, 2022

    GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

    Recruiting
    • GVHD
    • +15 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 30, 2021

    COVID-19 Trial in United States (Gimsilumab, Placebo)

    Completed
    Has Results
    • COVID-19
    • Phoenix, Arizona
    • +32 more
    Dec 10, 2021

    Trauma, Bleeding Trial (Deep-frozen platelets)

    Not yet recruiting
    • Trauma
    • Bleeding
    • Deep-frozen platelets
    • (no location specified)
    Aug 15, 2022

    Injectable Platelet Rich Fibrin and Microneedling in Interdental Papilla Reconstruction Trial in Cairo (Platelet-Rich Fibrin and

    Not yet recruiting
    • Injectable Platelet Rich Fibrin and Microneedling in Interdental Papilla Reconstruction
    • Platelet-Rich Fibrin and Microneedling
    • Cairo, Egypt
      Faculty of Dentistry ,Cairo University
    Aug 27, 2023